158 related articles for article (PubMed ID: 3856939)
1. Ferrochelatase deficiency in the bone marrow in a syndrome of congenital hypochromic microcytic anemia, hyperferremia, and iron overload of the liver.
Stavem P; Romslo I; Hovig T; Rootwelt K; Emblem R
Scand J Gastroenterol Suppl; 1985; 107():73-81. PubMed ID: 3856939
[TBL] [Abstract][Full Text] [Related]
2. Ferrochelatase deficiency of the bone marrow in a syndrome of congenital microcytic anaemia with iron overload of the liver and hyperferraemia.
Stavem P; Romslo I; Hovig T; Rootwelt K; Emblem R
Scand J Haematol; 1985 Feb; 34(2):204-6. PubMed ID: 3975573
[TBL] [Abstract][Full Text] [Related]
3. Congenital hypochromic microcytic anaemia with iron overload of the liver and hyperferraemia.
Stavem P; Saltvedt E; Elgjo K; Rootwelt K
Scand J Haematol; 1973; 10(2):153-60. PubMed ID: 4731089
[No Abstract] [Full Text] [Related]
4. Ferrochelatase deficiency in an infant with anemia and growth delay.
Carpentieri U; Buck ED; Minguell JJ; Balachandran S; Haggard ME
Pediatrics; 1979 May; 63(5):757-60. PubMed ID: 440897
[TBL] [Abstract][Full Text] [Related]
5. Heme metabolism and in vitro erythropoiesis in anemia associated with hypochromic microcytosis.
Brown AC; Lutton JD; Pearson HA; Nelson JC; Levere RD; Abraham NG
Am J Hematol; 1988 Jan; 27(1):1-6. PubMed ID: 3354554
[TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
Holme SA; Worwood M; Anstey AV; Elder GH; Badminton MN
Blood; 2007 Dec; 110(12):4108-10. PubMed ID: 17804693
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
[TBL] [Abstract][Full Text] [Related]
8. hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse.
Tian M; Campagna DR; Woodward LS; Justice MJ; Fleming MD
Blood; 2008 Nov; 112(10):4308-13. PubMed ID: 18780836
[TBL] [Abstract][Full Text] [Related]
9. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
[TBL] [Abstract][Full Text] [Related]
10. Congenital sideroblastic anemia without clinical iron overload. A case report.
Pignon JM; Breton-Gorius J; Bachir D; Rochant H
Nouv Rev Fr Hematol (1978); 1990; 32(4):281-4. PubMed ID: 2290714
[TBL] [Abstract][Full Text] [Related]
11. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
[TBL] [Abstract][Full Text] [Related]
12. Effect of total dose infusion of iron dextran on the stainable iron and erythropoiesis in bone marrow.
Perkash A; Sharma R; Devi PK
Indian J Med Res; 1970 Nov; 58(11):1608-12. PubMed ID: 5505349
[No Abstract] [Full Text] [Related]
13. Iron deficiency.
Bothwell TH
Med J Aust; 1972 Aug; 2(8):433-8. PubMed ID: 5086305
[No Abstract] [Full Text] [Related]
14. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
15. Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats.
Winter M; Funk J; Körner A; Alberati D; Christen F; Schmitt G; Altmann B; Pospischil A; Singer T
Exp Hematol; 2016 Oct; 44(10):964-974.e4. PubMed ID: 27403535
[TBL] [Abstract][Full Text] [Related]
16. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin production and liver involvement in a patient with erythropoietic protoporphyria.
Romslo I; Høvding G; Hamre E; Laerum OD
Scand J Clin Lab Invest; 1978 Oct; 38(6):529-35. PubMed ID: 705235
[TBL] [Abstract][Full Text] [Related]
18. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
Cooperman SS; Meyron-Holtz EG; Olivierre-Wilson H; Ghosh MC; McConnell JP; Rouault TA
Blood; 2005 Aug; 106(3):1084-91. PubMed ID: 15831703
[TBL] [Abstract][Full Text] [Related]
19. Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).
Steensma DP; Hecksel KA; Porcher JC; Lasho TL
Leuk Res; 2007 May; 31(5):623-8. PubMed ID: 16870250
[TBL] [Abstract][Full Text] [Related]
20. Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice.
Cherukuri S; Tripoulas NA; Nurko S; Fox PL
Blood Cells Mol Dis; 2004; 33(3):346-55. PubMed ID: 15528156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
